BioCentury
ARTICLE | Company News

Afinitor sales and marketing update

November 17, 2016 10:46 PM UTC

The U.K.'s NICE issued a final appraisal determination (FAD) recommending the use of Afinitor everolimus from Novartis in combination with exemestane to treat advanced EGFR2 (HER2; ErbB2; neu)-negativ...